コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 tin, and red blood cell lysate (representing hemosiderin).
2 big granular, irregular, and brown pigments (hemosiderin).
3 ells, and dermal deposition of periostin and hemosiderin.
4 epatocytes that contained greater amounts of hemosiderin.
5 treatments, exhibited increased deposits of hemosiderin.
8 ses and a striking increase in the number of hemosiderin-containing macrophages is observed associate
9 sions (ARIA-E) and ARIA-microhemorrhages and hemosiderin deposition (ARIA-H) were higher with donanem
11 -type levels) exhibited a similar pattern of hemosiderin deposition and fibrosis in their hearts.
13 mosiderinuria associated with marked tubular hemosiderin deposition and HO-1 induction, while there w
15 This destructive process is characterized by hemosiderin deposition in the superficial and deeper lay
17 y those with both fatty liver and coexistent hemosiderin deposition or radiologically occult diffuse
18 id level, incomplete hypointense ring due to hemosiderin deposition, pseudotumor-like growth, pseudoc
20 racteristics of human CCM lesions, including hemosiderin deposits, immune cell infiltration, increase
21 e termed ARIA-E, whereas those consisting of hemosiderin deposits, including parenchymal microhemorrh
22 nomenon, distended vessels, damaged vessels, hemosiderin deposits, vessel tortuosity, and microaneury
23 load may cause change in some liver markers (hemosiderin depots, apoptosis index and GPx) and blood l
24 nd ALT; (5) liver histology (histopathology, hemosiderin depots, apoptosis index; (6) liver fatty aci
29 models could be differentiated according to hemosiderin iron accumulation-both in tumors and systemi
31 n of LysM-Atg5-/- mice, correlating with low hemosiderin iron storage, as well as in erythrophagocyti
32 r growth in mouse models while also reducing hemosiderin iron-laden TAM accumulation as measured by b
33 rogressively bloodier return and/or over 20% hemosiderin-laden macrophages in diffuse alveolar hemorr
38 nion exchange) and Mallory's stain for iron (hemosiderin), markers of previous intraplaque hemorrhage
40 While taking gantenerumab, ARIA-E and ARIA-hemosiderin occurred in 24.9% (247 of 993) and 22.9% (22
41 r Development Index score (P=0.02) and brain hemosiderin (P=0.04) remained significantly associated w
42 the putamen consistent with accumulation of hemosiderin (posterior portion) and neuromelanin (remain
43 ges all decreased over time, suggesting that hemosiderin products undergo continued, subtle evolution
46 , hemorrhage, fibrohistiocytic reaction with hemosiderin, sclerosis or fibrosis, and sclerohyalinosis
47 , hemorrhage, fibrohistiocytic reaction with hemosiderin, sclerosis or fibrosis, which were also expr
48 ophagocytic macrophages, autophagy regulates hemosiderin storage mechanisms as well as degradation of